• NHE1 Links Olfr2 to Macrophage Atherosclerosis

  2026-08-12

  The reference study identifies macrophage NHE1 as a downstream effector of octanal–Olfr2 signaling in atherosclerosis, connecting calcium-dependent ROS production with NLRP3 inflammasome-associated inflammation. Its combined mouse and macrophage experiments suggest that NHE1 is mechanistically important, although validation in human and primary-cell systems remains necessary.

• ML385: Practical NRF2 Inhibition Workflows

  2026-08-12

  ML385 enables controlled NRF2 pathway suppression for non-small cell lung cancer research, therapeutic-resistance studies, and oxidative-stress experiments. This guide translates its mechanism into dose-finding, pathway-validation, combination-treatment, and troubleshooting workflows, while showing how recent osteoclast research broadens its experimental value.

• TMEM16F in Kupffer Cells Protects Against Listeria

  2026-08-11

  This study identifies Kupffer cell-expressed TMEM16F as the critical cell-specific determinant protecting the liver during Listeria monocytogenes infection. Its membrane-repair and lipid-scrambling functions limit Kupffer cell rupture, inflammatory injury, and infection-associated metabolic dysregulation.

• WM-8014: KAT6A Inhibitor Workflow Guide

  2026-08-11

  WM-8014 is a reversible, competitive KAT6A/B inhibitor suited to linking epigenetic mechanism with cell-cycle and senescence phenotypes. This workflow guide shows how to build dose-time matrices, validate oncogene-induced senescence, and troubleshoot solubility, serum-binding, and model-selection problems.

• AICAR phosphate (Acadesine): Assay Guide

  2026-08-10

  A scenario-based guide to using AICAR phosphate (Acadesine), SKU B1211, in viability, proliferation, and apoptosis assays. It connects AMPK biology with practical decisions about concentration selection, controls, formulation, interpretation, and reagent reliability.

• Angiotensin I/II (1-5) Protocol Guide

  2026-08-09

  Angiotensin I/II (1-5) provides a defined Asp-Arg-Val-Tyr-Ile peptide fragment for controlled renin-angiotensin system research involving cardiovascular and renal workflows. It should be used with solvent and stability controls, not as a substitute for parent angiotensin peptides or as a general-purpose reagent for unrelated signaling studies.

• ACE2 Activation in Sepsis-Induced Cardiomyopathy

  2026-08-08

  The reference study identifies ACE2 downregulation as a feature of sepsis-induced cardiomyopathy and shows that pharmacological ACE2 activation with Diminazene Aceturate protects septic mouse hearts. Its central mechanistic contribution is linking ACE2–Mas receptor–Sirt1 signaling with mitochondrial biogenesis, while the inhibitor-based comparison strengthens the interpretation that this pathway contributes to cardiac injury.

• Quizartinib (AC220): From FLT3 Biology to Translation

  2026-08-07

  Quizartinib (AC220) offers a precise way to interrogate FLT3 dependence in acute myeloid leukemia research. This thought-leadership article connects FLT3 autophosphorylation inhibition with experimental design, resistance biology, xenograft translation, and the broader implications of FLT3 signaling beyond AML.

• SP1/ADAM10/DRP1 Axis Mediates SMC–EC Crosstalk in Hypoxia Pu

  2026-08-07

  This study reveals how the SP1/ADAM10/DRP1 signaling axis orchestrates communication between endothelial and smooth muscle cells under hypoxic conditions in pulmonary hypertension. The findings highlight ADAM10 as a mediator of pathological SMC proliferation, offering new insights for therapeutic intervention.

• Diminazene Aceturate in Research: Reliable Workflows & Data

  2026-08-06

  This article addresses common experimental challenges in cell viability and mitochondrial biogenesis studies, demonstrating how Diminazene Aceturate (SKU B1729) provides reproducible and data-driven solutions. Researchers will gain scenario-based insights backed by recent literature and practical protocol guidance for reliable results.

• Diminazene Aceturate in Mitochondrial Biogenesis and Parasit

  2026-08-06

  Diminazene Aceturate is redefining experimental design in both trypanosome parasite research and studies of mitochondrial biogenesis, notably in sepsis-induced cardiomyopathy models. Its dual-action profile, high solubility, and proven effect on ACE2 activation make it an essential tool for translational infection and cardiovascular research.

• Cyclodextrin-Coated Magnetic Nanoparticles for Uremic Toxin

  2026-08-05

  This study presents a systematic evaluation of cyclodextrin-functionalized magnetic nanoparticles for the adsorption of protein-bound uremic toxins relevant to chronic kidney disease. The work highlights the physicochemical factors that govern toxin capture, with implications for next-generation blood purification materials.

• RESTRICT-seq Reveals KAT6A/B as Epigenetic Dependencies in S

  2026-08-05

  The reference study introduces RESTRICT-seq, a time-gated CRISPR screening method that uncovers novel epigenetic regulators sustaining squamous cell carcinoma (SCC) resistance. By identifying KAT6A and KAT6B as critical dependencies, the work highlights new avenues for targeted senescence induction and epigenetic therapy in cancer biology.

• TPCA-1 (SKU A4602): Reliable IKK-2 Inhibition for Inflammati

  2026-08-04

  This article delivers an evidence-based, scenario-driven guide to addressing common laboratory challenges in inflammation and cell viability assays using TPCA-1 (SKU A4602). Drawing on quantitative data, recent literature, and workflow insights, it demonstrates how this selective IKK-2 inhibitor from APExBIO ensures reliable inhibition of the NF-κB pathway, supporting both experimental reproducibility and advanced disease modeling.

• O-GlcNAcylation Links Wnt Signaling to Glycolytic Bone Forma

  2026-08-04

  This study reveals that O-GlcNAcylation is essential for Wnt-driven bone formation by directly regulating glycolytic metabolism in osteoblasts. The findings clarify a previously unknown post-translational mechanism behind Wnt-induced osteogenesis, providing new insights for targeting skeletal diseases.

16213 records 1/1081 page Next 12345 下5页 Last page